BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 19855087)

  • 1. Fas ligand expression on T cells is sufficient to prevent prolonged airway inflammation in a murine model of asthma.
    Tong J; Clay BS; Ferreira CM; Bandukwala HS; Moore TV; Blaine KM; Williams JW; Hoffman LM; Hamann KJ; Shilling RA; Weinstock JV; Sperling AI
    Am J Respir Cell Mol Biol; 2010 Sep; 43(3):342-8. PubMed ID: 19855087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas-positive T cells regulate the resolution of airway inflammation in a murine model of asthma.
    Tong J; Bandulwala HS; Clay BS; Anders RA; Shilling RA; Balachandran DD; Chen B; Weinstock JV; Solway J; Hamann KJ; Sperling AI
    J Exp Med; 2006 May; 203(5):1173-84. PubMed ID: 16618792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low doses of exogenous interferon-γ attenuated airway inflammation through enhancing Fas/FasL-induced CD4+ T cell apoptosis in a mouse asthma model.
    Yao Y; Lu S; Li H; Lu G; Zhou J
    J Interferon Cytokine Res; 2012 Nov; 32(11):534-41. PubMed ID: 22994871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fas-ligand-expressing adenovirus-transfected dendritic cells decrease allergen-specific T cells and airway inflammation in a murine model of asthma.
    Chuang YH; Suen JL; Chiang BL
    J Mol Med (Berl); 2006 Jul; 84(7):595-603. PubMed ID: 16565865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas ligand (gld)- and Fas (lpr)-deficient mice do not show alterations in the extravasation or apoptosis of inflammatory neutrophils.
    Fecho K; Cohen PL
    J Leukoc Biol; 1998 Sep; 64(3):373-83. PubMed ID: 9738665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic sialadenitis in a murine model of Sjögren's syndrome by local fasL gene transfer.
    Fleck M; Zhang HG; Kern ER; Hsu HC; Müller-Ladner U; Mountz JD
    Arthritis Rheum; 2001 Apr; 44(4):964-73. PubMed ID: 11315936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutting edge: FasL(+) immune cells promote resolution of fibrosis.
    Wallach-Dayan SB; Elkayam L; Golan-Gerstl R; Konikov J; Zisman P; Dayan MR; Arish N; Breuer R
    J Autoimmun; 2015 May; 59():67-76. PubMed ID: 25812467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fas-FasL interaction involved in pathogenesis of ocular toxoplasmosis in mice.
    Hu MS; Schwartzman JD; Yeaman GR; Collins J; Seguin R; Khan IA; Kasper LH
    Infect Immun; 1999 Feb; 67(2):928-35. PubMed ID: 9916110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Egr-2 in up-regulation of Fas ligand in normal T cells and aberrant double-negative lpr and gld T cells.
    Mittelstadt PR; Ashwell JD
    J Biol Chem; 1999 Jan; 274(5):3222-7. PubMed ID: 9915863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymphocytes with aberrant expression of Fas or Fas ligand attenuate immune bone marrow failure in a mouse model.
    Omokaro SO; Desierto MJ; Eckhaus MA; Ellison FM; Chen J; Young NS
    J Immunol; 2009 Mar; 182(6):3414-22. PubMed ID: 19265119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergen Exposure in Lymphopenic Fas-Deficient Mice Results in Persistent Eosinophilia Due to Defects in Resolution of Inflammation.
    Ferreira CM; Williams JW; Tong J; Rayon C; Blaine KM; Sperling AI
    Front Immunol; 2018; 9():2395. PubMed ID: 30425708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fas-mediated cytotoxicity is not required for rejection of murine nonvascularized heterotopic cardiac allografts.
    Djamali A; Odorico JS
    Transplantation; 1998 Dec; 66(12):1793-801. PubMed ID: 9884278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of effector T cells and Fas ligand on lupus-associated B cells.
    Fields ML; Nish SA; Hondowicz BD; Metzgar MH; Wharton GN; Caton AJ; Erikson J
    J Immunol; 2005 Jul; 175(1):104-11. PubMed ID: 15972636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas ligand-deficient gld mice are more susceptible to graft-versus-host-disease.
    van den Brink MR; Moore E; Horndasch KJ; Crawford JM; Murphy GF; Burakoff SJ
    Transplantation; 2000 Jul; 70(1):184-91. PubMed ID: 10919598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fas/Fas ligand-mediated apoptosis promotes hypersensitivity pneumonitis in mice by enhancing maturation of dendritic cells.
    Hwang SJ; Kim HS; Chung DH
    Am J Respir Crit Care Med; 2010 Jun; 181(11):1250-61. PubMed ID: 20194815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Graft-versus-host-disease-associated donor cell engraftment in an F1 hybrid model is dependent upon the Fas pathway.
    Iwasaki T; Hamano T; Saheki K; Kuroiwa T; Kataoka Y; Takemoto Y; Ogata A; Fujimoto J; Kakishita E
    Immunology; 2000 Jan; 99(1):94-100. PubMed ID: 10651946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Fas/FasL pathway in the activation of infiltrating cells in murine acute myocarditis caused by Coxsackievirus B3.
    Seko Y; Kayagaki N; Seino K; Yagita H; Okumura K; Nagai R
    J Am Coll Cardiol; 2002 Apr; 39(8):1399-403. PubMed ID: 11955862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor regression after adoptive transfer of effector T cells is independent of perforin or Fas ligand (APO-1L/CD95L).
    Winter H; Hu HM; Urba WJ; Fox BA
    J Immunol; 1999 Oct; 163(8):4462-72. PubMed ID: 10510388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of functional Fas ligand enhances intestinal tumorigenesis in the Min mouse model.
    Fingleton B; Carter KJ; Matrisian LM
    Cancer Res; 2007 May; 67(10):4800-6. PubMed ID: 17510409
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF but not Fas ligand provides protective anti-L. major immunity in C57BL/6 mice.
    Wilhelm P; Wiede F; Meissner A; Donhauser N; Bogdan C; Körner H
    Microbes Infect; 2005 Dec; 7(15):1461-8. PubMed ID: 16269265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.